These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30870868)

  • 1. [The Cardiorenal Syndrome].
    Brandenburg V; Heine GH
    Dtsch Med Wochenschr; 2019 Mar; 144(6):382-386. PubMed ID: 30870868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic therapies for chronic and acute decompensated heart failure: specific insights on cardiorenal syndromes.
    Roubille F; Morena M; Leray-Moragues H; Canaud B; Cristol JP; Klouche K
    Blood Purif; 2014; 37 Suppl 2():20-33. PubMed ID: 25196566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorenal protection during chronic renin-angiotensin-aldosterone system suppression: evidences and caveats.
    Ruiz-Hurtado G; Ruilope LM
    Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):126-31. PubMed ID: 27533982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiorenal syndrome].
    Alscher MD; Sechtem U
    Internist (Berl); 2012 Mar; 53(3):309-17; quiz 318. PubMed ID: 22274302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclical cardiorenal syndrome in late-stage kidney disease
.
    Ku BS; Fishbane S
    Clin Nephrol; 2018 Sep; 90(3):180-184. PubMed ID: 29701173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially.
    Palazzuoli A; Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):503-8. PubMed ID: 21822604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role and Mechanism of the Renin-Angiotensin-Aldosterone System in the Onset and Development of Cardiorenal Syndrome.
    Ma K; Gao W; Xu H; Liang W; Ma G
    J Renin Angiotensin Aldosterone Syst; 2022; 2022():3239057. PubMed ID: 35111237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiorenal syndrome: what the cardiologist needs to know.
    Waldum B; Os I
    Cardiology; 2013; 126(3):175-86. PubMed ID: 24022166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting to the Heart of the Matter: Review of Treatment of Cardiorenal Syndrome.
    Umanath K; Emani S
    Adv Chronic Kidney Dis; 2017 Jul; 24(4):261-266. PubMed ID: 28778367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes.
    Humalda JK; Goldsmith DJ; Thadhani R; de Borst MH
    Nephrol Dial Transplant; 2015 Dec; 30(12):1988-94. PubMed ID: 25609737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Clinical Approach to the Acute Cardiorenal Syndrome.
    Jentzer JC; Chawla LS
    Crit Care Clin; 2015 Oct; 31(4):685-703. PubMed ID: 26410138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome.
    Giam B; Kaye DM; Rajapakse NW
    Heart Lung Circ; 2016 Aug; 25(8):874-80. PubMed ID: 27132623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiorenal Syndrome: An Important Subject in Nephrocardiology.
    Hatamizadeh P
    Cardiol Clin; 2021 Aug; 39(3):455-469. PubMed ID: 34247758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negotiating renal dysfunction when treating patients with heart failure.
    Carubelli V; Metra M; Lund LH
    Expert Rev Cardiovasc Ther; 2018 Feb; 16(2):113-122. PubMed ID: 29292652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorenal syndrome: long road between kidney and heart.
    Junho CVC; Trentin-Sonoda M; Panico K; Dos Santos RSN; Abrahão MV; Vernier ICS; Fürstenau CR; Carneiro-Ramos MS
    Heart Fail Rev; 2022 Nov; 27(6):2137-2153. PubMed ID: 35133552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiorenal syndrome--alternate challenge for nephrologist].
    Walatek B; Sułowicz W
    Przegl Lek; 2011; 68(9):619-28. PubMed ID: 22335013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?
    Sexton DJ
    Circ Heart Fail; 2014 May; 7(3):536. PubMed ID: 24847129
    [No Abstract]   [Full Text] [Related]  

  • 19. Do Renin-Angiotensin Blockers Affect Renal Function and Cardiac Outcomes in Patients Undergoing Partial Nephrectomy?
    Nyame YA; Liang H; Arora HC; Gill BC; Caputo P; Ramirez D; Maurice MJ; Fareed K; Stein RJ; Haber GP; Stephenson AJ; Fergany A; Kaouk J
    J Urol; 2017 Mar; 197(3 Pt 1):566-573. PubMed ID: 27746281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
    Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.